See more : Interroll Holding AG (0QN2.L) Income Statement Analysis – Financial Results
Complete financial analysis of Immunovia AB (publ) (IMMNOV.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Immunovia AB (publ), a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Science Group plc (SAG.L) Income Statement Analysis – Financial Results
- Apacer Technology Inc. (8271.TW) Income Statement Analysis – Financial Results
- Icelandair Group hf. (ICEAIR.IC) Income Statement Analysis – Financial Results
- Foseco India Limited (FOSECOIND.NS) Income Statement Analysis – Financial Results
- Ledyard Financial Group, Inc. (LFGP) Income Statement Analysis – Financial Results
Immunovia AB (publ) (IMMNOV.ST)
About Immunovia AB (publ)
Immunovia AB (publ), a diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company's product includes IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. It also develops research projects for lung cancer. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.58M | 1.15M | 844.00K | 362.00K | 356.00K | 332.60K | 148.96K | 177.28K | 205.19K | 359.17K | 1.18M | 208.81K |
| Cost of Revenue | 6.68M | 4.21M | -14.97M | -40.02M | -26.72M | -25.05M | -24.04M | -24.29M | -16.79M | 7.28M | 1.70M | 190.70K |
| Gross Profit | -5.11M | -3.07M | 15.81M | 40.38M | 27.07M | 25.38M | 24.19M | 24.47M | 17.00M | -6.92M | -525.76K | 18.12K |
| Gross Profit Ratio | -324.25% | -267.77% | 1,873.58% | 11,155.25% | 7,604.49% | 7,632.32% | 16,238.78% | 13,802.69% | 8,283.16% | -1,928.05% | -44.61% | 8.68% |
| Research & Development | 34.42M | 47.90M | 43.00M | 48.10M | 34.20M | 26.05M | 24.04M | 24.29K | 16.79M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 82.61M | 91.15M | 78.32M | 65.28M | 39.11M | 24.12M | 17.38M | 7.55M | 1.88M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 148.30M | -47.90M | 82.61M | 91.15M | 78.32M | 65.28M | 39.11M | 24.12M | 17.38M | 7.55M | 1.88M | 20.00K |
| Other Expenses | 108.63M | 188.14M | 99.95M | 83.91M | 63.10M | 221.22K | 30.65M | 25.33K | 10.82K | 1.77M | 917.15K | 0.00 |
| Operating Expenses | 291.35M | 188.14M | 182.55M | 175.06M | 141.42M | 113.84M | 69.77M | 39.48M | 24.43M | 9.32M | 2.79M | 288.92K |
| Cost & Expenses | 298.04M | 192.35M | 167.59M | 135.04M | 114.71M | 88.79M | 45.73M | 15.19M | 7.64M | 9.32M | 2.79M | 479.62K |
| Interest Income | 2.92M | 745.00K | 710.00K | 576.00K | 285.00K | 318.59K | 297.73K | 255.93K | 41.28K | 100.90K | 20.34K | 11.90K |
| Interest Expense | 1.17M | 1.60M | 1.43M | 1.42M | 1.32M | 697.00 | 10.17K | 1.15K | 822.00 | 486.00 | 3.11K | 0.00 |
| Depreciation & Amortization | 141.72M | 24.91M | 19.06M | 9.76M | 8.45M | 2.78M | 1.26M | 523.97K | 288.28K | 562.25K | 499.47K | 268.92K |
| EBITDA | -166.56M | -141.58M | -135.47M | -134.85M | -104.75M | -83.75M | -43.97M | -14.20M | -7.10M | -8.60M | -1.10M | -1.89K |
| EBITDA Ratio | -10,575.17% | -12,364.98% | -16,051.07% | -37,251.93% | -29,424.72% | -25,181.76% | -29,509.69% | -7,994.71% | -3,457.51% | -2,309.90% | -92.81% | -0.90% |
| Operating Income | -296.46M | -191.15M | -166.74M | -134.68M | -114.35M | -87.71M | -45.52M | -14.98M | -7.42M | -8.96M | -1.61M | -270.80K |
| Operating Income Ratio | -18,822.86% | -16,694.32% | -19,756.04% | -37,203.87% | -32,120.79% | -26,371.06% | -30,557.77% | -8,448.60% | -3,618.12% | -2,494.54% | -136.91% | -129.69% |
| Total Other Income/Expenses | -12.98M | 23.06M | 10.66M | -11.69M | -269.00K | 1.18M | 287.56K | 254.79K | 40.46K | 100.41K | 17.23K | 11.90K |
| Income Before Tax | -309.44M | -168.09M | -155.97M | -146.03M | -114.52M | -86.53M | -45.23M | -14.72M | -7.38M | -8.86M | -1.60M | -258.91K |
| Income Before Tax Ratio | -19,646.92% | -14,680.52% | -18,479.38% | -40,340.61% | -32,167.70% | -26,017.02% | -30,364.72% | -8,304.88% | -3,598.41% | -2,466.58% | -135.45% | -123.99% |
| Income Tax Expense | 0.00 | -23.06M | 1.43M | 1.42M | 4.00K | 7.35K | 297.73K | 255.93K | 41.28K | 100.90K | 20.34K | 0.00 |
| Net Income | -309.44M | -145.03M | -157.40M | -147.45M | -114.52M | -86.54M | -45.23M | -14.72M | -7.38M | -8.86M | -1.60M | -258.91K |
| Net Income Ratio | -19,646.92% | -12,666.72% | -18,649.05% | -40,732.32% | -32,168.82% | -26,019.22% | -30,364.72% | -8,304.88% | -3,598.41% | -2,466.58% | -135.45% | -123.99% |
| EPS | -3.95 | -5.95 | -6.45 | -6.41 | -5.43 | -4.33 | -2.48 | -0.91 | -0.60 | -0.74 | -0.13 | -0.02 |
| EPS Diluted | -3.95 | -5.95 | -6.45 | -6.41 | -5.43 | -4.33 | -2.48 | -0.91 | -0.60 | -0.71 | -0.13 | -0.02 |
| Weighted Avg Shares Out | 78.37M | 24.39M | 24.39M | 22.99M | 21.09M | 19.98M | 18.25M | 16.15M | 12.31M | 11.90M | 11.90M | 11.90M |
| Weighted Avg Shares Out (Dil) | 78.37M | 24.39M | 24.39M | 22.99M | 21.09M | 19.98M | 18.25M | 16.15M | 12.31M | 12.50M | 12.50M | 12.50M |
Source: https://incomestatements.info
Category: Stock Reports